Australia Changes Patent Notification Requirements
Generic And Biosimilar Filers Must Notify Patent Holders Before TGA Evaluation
Australia’s Therapeutic Goods Administration has set out proposals for a change to early-notification requirements for generic and biosimilar sponsors.
You may also be interested in...
From 20 October, a free online platform will allow registrants attending the digital Global Generics & Biosimilars Awards 2020 to participate in two weeks of dedicated networking activities ahead of the ceremony on 3 November.
In this podcast discussion, Generics Bulletin editor David Wallace talks to Duncan Emerton, director of Custom Intelligence and Analytics for Informa Pharma Intelligence, about the UK's new licensing procedure for biosimilars.
Despite the average trade price of ciprofloxacin shooting up in September, no UK price concessions were granted by the DHSC.